AI Chat Paper
Discover the SciOpen Platform and Achieve Your Research Goals with Ease.
Search articles, authors, keywords, DOl and etc.
{{expandStatus?'Exit ':''}}Advanced Search
Theranostic nanoparticles are integrated systems useful for simultaneous diagnosis and imaging guided delivery of therapeutic drugs, with wide ranging potential applications in the clinic. Here we developed a theranostic nanoparticle (~ 24 nm size by dynamic light scattering) p-FE-PTX-FA based on polymeric micelle encapsulating an organic dye (FE) fluorescing in the 1, 000–1, 700 nm second near-infrared (NIR-II) window and an anti-cancer drug paclitaxel. Folic acid (FA) was conjugated to the nanoparticles to afford specific binding to molecular folate receptors on murine breast cancer 4T1 tumor cells. In vivo, the nanoparticles accumulated in 4T1 tumor through both passive and active targeting effect. Under an 808 nm laser excitation, fluorescence detection above 1, 300 nm afforded a large Stokes shift, allowing targeted molecular imaging tumor with high signal to background ratios, reaching a high tumor to normal tissue signal ratio (T/NT) of (20.0 ± 2.3). Further, 4T1 tumors on mice were completed eradicated by paclitaxel released from p-FE-PTA-FA within 20 days of the first injection. Pharmacokinetics and histology studies indicated p-FE-PTX-FA had no obvious toxic side effects to major organs. This represented the first NIR-II theranostic agent developed.
Janib, S. M.; Moses, A. S.; MacKay, J. A. Imaging and drug delivery using theranostic nanoparticles. Adv. Drug Deliv. Rev. 2010, 62, 1052–1063.
Wicki, A.; Witzigmann, D.; Balasubramanian, V.; Huwyler, J. Nanomedicine in cancer therapy: Challenges, opportunities, and clinical applications. J. Control. Release 2015, 200, 138–157.
Maeda, H.; Nakamura, H.; Fang, J. The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo. Adv. Drug Deliv. Rev. 2013, 65, 71–79.
Cole, A. J.; Yang, V. C.; David, A. E. Cancer theranostics: The rise of targeted magnetic nanoparticles. Trends Biotechnol. 2011, 29, 323–332.
Lee, G. Y.; Qian, W. P.; Wang, L. Y.; Wang, Y. A.; Staley, C. A.; Satpathy, M.; Nie, S. M.; Mao, H.; Yang, L. Theranostic nanoparticles with controlled release of gemcitabine for targeted therapy and MRI of pancreatic cancer. ACS Nano 2013, 7, 2078–2089.
Liu, T.; Wu, G. Y.; Cheng, J. J.; Lu, Q.; Yao, Y. J.; Liu, Z. J.; Zhu, D. C.; Zhou, J.; Xu, J. R.; Zhu, J. et al. Multifunctional lymph-targeted platform based on Mn@mSiO2 nanocomposites: Combining PFOB for dual-mode imaging and DOX for cancer diagnose and treatment. Nano Res. 2016, 9, 473–489.
Zhou, M.; Song, S. L.; Zhao, J.; Tian, M.; Li, C. Theranostic CuS nanoparticles targeting folate receptors for PET image-guided photothermal therapy. J. Mater. Chem. B 2015, 3, 8939–8948.
Baum, R. P.; Kulkarni, H. R. THERANOSTICS: From molecular imaging using Ga-68 labeled tracers and PET/CT to personalized radionuclide therapy—The Bad Berka experience. Theranostics 2012, 2, 437–447.
Nurunnabi, M.; Cho, K. J.; Choi, J. S.; Huh, K. M.; Lee, Y. K. Targeted near-IR QDs-loaded micelles for cancer therapy and imaging. Biomaterials 2010, 31, 5436–5444.
Ge, J. C.; Jia, Q. Y.; Liu, W. M.; Guo, L.; Liu, Q. Y.; Lan, M. H.; Zhang, H. Y.; Meng, X. M.; Wang, P. F. Red‐emissive carbon dots for fluorescent, photoacoustic, and thermal theranostics in living mice. Adv. Mater. 2015, 27, 4169–4177.
Wu, X. M.; Sun, X. R.; Guo, Z. Q.; Tang, J. B.; Shen, Y. Q.; James, T. D.; Tian, H.; Zhu, W. H. In vivo and in situ tracking cancer chemotherapy by highly photostable NIR fluorescent theranostic prodrug. J. Am. Chem. Soc. 2014, 136, 3579–3588.
Smith, B. R.; Gambhir, S. S. Nanomaterials for in vivo imaging. Chem. Rev. 2017, 117, 901–986.
Stolik, S.; Delgado, J. A.; Pérez, A.; Anasagasti, L. Measurement of the penetration depths of red and near infrared light in human "ex vivo" tissues. J. Photochem. Photobiol. B 2000, 57, 90–93.
Frangioni, J. V. In vivo near-infrared fluorescence imaging. Curr. Opin. Chem. Biol. 2003, 7, 626–634.
Tagaya, N.; Yamazaki, R.; Nakagawa, A.; Abe, A.; Hamada, K.; Kubota, K.; Oyama, T. Intraoperative identification of sentinel lymph nodes by near- infrared fluorescence imaging in patients with breast cancer. Am. J. Surg. 2008, 195, 850–853.
He, X. X.; Wu, X.; Wang, K. M.; Shi, B. H.; Hai, L. Methylene blue- encapsulated phosphonate-terminated silica nanoparticles for simultaneous in vivo imaging and photodynamic therapy. Biomaterials 2009, 30, 5601– 5609.
Smith, A. M.; Mancini, M. C.; Nie, S. M. Bioimaging: Second window for in vivo imaging. Nat. Nanotechnol. 2009, 4, 710–711.
Hong, G. S.; Diao, S.; Chang, J. L.; Antaris, A. L.; Chen, C. X.; Zhang, B.; Zhao, S.; Atochin, D. N.; Huang, P. L.; Andreasson, K. I. et al. Through- skull fluorescence imaging of the brain in a new near-infrared window. Nat. Photonics 2014, 8, 723–730.
Diao, S.; Blackburn, J. L.; Hong, G. S.; Antaris, A. L.; Chang, J. L.; Wu, J. Z.; Zhang, B.; Cheng, K.; Kuo, C. J.; Dai, H. J. Fluorescence imaging in vivo at wavelengths beyond 1500 nm. Angew. Chem. 2015, 127, 14971– 14975.
Zebibula, A.; Alifu, N.; Xia, L. Q.; Sun, C. W.; Yu, X. M.; Xue, D. W.; Liu, L. W.; Li, G. H.; Qian, J. Ultrastable and biocompatible NIR‐Ⅱ quantum dots for functional bioimaging. Adv. Funct. Mater. 2018, 28, 1703451.
Naczynski, D. J.; Tan, M. C.; Zevon, M.; Wall, B.; Kohl, J.; Kulesa, A.; Chen, S.; Roth, C. M.; Riman, R. E.; Moghe, P. V. Rare-earth-doped biological composites as in vivo shortwave infrared reporters. Nat. Commun. 2013, 4, 2199.
Singla, A. K.; Garg, A.; Aggarwal, D. Paclitaxel and its formulations. Int. J. Pharm. 2002, 235, 179–192.
Kim, S. C.; Kim, D. W.; Shim, Y. H.; Bang, J. S.; Oh, H. S.; Kim, S. W.; Seo, M. H. In vivo evaluation of polymeric micellar paclitaxel formulation: Toxicity and efficacy. J. Control. Release 2001, 72, 191–202.
Yang, Q. L.; Ma, Z. R.; Wang, H. S.; Zhou, B.; Zhu, S. J.; Zhong, Y. T.; Wang, J. Y.; Wan, H.; Antaris, A.; Ma, R. et al. Rational design of molecular fluorophores for biological imaging in the NIR‐Ⅱ window. Adv. Mater. 2017, 29, 1605497.
Wan, H.; Yue, J. Y.; Zhu, S. J.; Uno, T.; Zhang, X. D.; Yang, Q. L.; Yu, K.; Hong, G. S.; Wang, J. Y.; Li, L. L. et al. A bright organic NIR-Ⅱ nanofluorophore for three-dimensional imaging into biological tissues. Nat. Commun. 2018, 9, 1171.
Liu, Z.; Chen, K.; Davis, C.; Sherlock, S.; Cao, Q. Z.; Chen, X. Y.; Dai, H. J. Drug delivery with carbon nanotubes for in vivo cancer treatment. Cancer Res. 2008, 68, 6652–6660.
Chen, L. X.; Zhang, Y. M.; Cao, Y.; Zhang, H. Y.; Liu, Y. Bridged bis(β-cyclodextrin)s-based polysaccharide nanoparticles for controlled paclitaxel delivery. RSC Adv. 2016, 6, 28593–28598.
Song, Y. C.; Shi, W.; Chen, W.; Li, X. H.; Ma, H. M. Fluorescent carbon nanodots conjugated with folic acid for distinguishing folate-receptor-positive cancer cells from normal cells. J. Mater. Chem. 2012, 22, 12568–12573.
Biabanikhankahdani, R.; Bayat, S.; Ho, K. L.; Alitheen, N. B. M.; Tan, W. S. A simple add-and-display method for immobilisation of cancer drug on his-tagged virus-like nanoparticles for controlled drug delivery. Sci. Rep. 2017, 7, 5303.
Murphy, J. E.; Beard, M. C.; Norman, A. G.; Ahrenkiel, S. P.; Johnson, J. C.; Yu, P. R.; Mićić, O. I.; Ellingson, R. J.; Nozik, A. J. PbTe colloidal nanocrystals: Synthesis, characterization, and multiple exciton generation. J. Am. Chem. Soc. 2006, 128, 3241–3247.
Sun, Y.; Qu, C. R.; Chen, H.; He, M. M.; Tang, C.; Shou, K. Q.; Hong, S.; Yang, M.; Jiang, Y. X.; Ding, B. B. et al. Novel benzo-bis(1, 2, 5-thiadiazole) fluorophores for in vivo NIR-Ⅱ imaging of cancer. Chem. Sci. 2016, 7, 6203–6207.
Semonin, O. E.; Johnson, J. C.; Luther, J. M.; Midgett, A. G.; Nozik, A. J.; Beard, M. C. Absolute photoluminescence quantum yields of IR-26 dye, PbS, and PbSe quantum dots. J. Phys. Chem. Lett. 2010, 1, 2445–2450.
Hatami, S.; Würth, C.; Kaiser, M.; Leubner, S.; Gabriel, S.; Bahrig, L.; Lesnyak, V.; Pauli, J.; Gaponik, N.; Eychmüller, A. et al. Absolute photoluminescence quantum yields of IR26 and IR-emissive Cd1−x Hgx Te and PbS quantum dots—Method- and material-inherent challenges. Nanoscale 2015, 7, 133–143.
Welsher, K.; Liu, Z.; Sherlock, S. P.; Robinson, J. T.; Chen, Z.; Daranciang, D.; Dai, H. J. A route to brightly fluorescent carbon nanotubes for near- infrared imaging in mice. Nat. Nanotechnol. 2009, 4, 773–780.
Hong, G. S.; Lee, J. C.; Robinson, J. T.; Raaz, U.; Xie, L. M.; Huang, N. F.; Cooke, J. P.; Dai, H. J. Multifunctional in vivo vascular imaging using near-infrared Ⅱ fluorescence. Nat. Med. 2012, 18, 1841–1846.
Alibolandi, M.; Abnous, K.; Sadeghi, F.; Hosseinkhani, H.; Ramezani, M.; Hadizadeh, F. Folate receptor-targeted multimodal polymersomes for delivery of quantum dots and doxorubicin to breast adenocarcinoma: In vitro and in vivo evaluation. Int. J. Pharm. 2016, 500, 162–178.
Karimi Shervedani, R.; Yaghoobi, F.; Torabi, M.; Samiei Foroushani, M. Nanobioconjugated system formed of folic acid–deferrioxamine–Ga(Ⅲ) on gold surface: Preparation, characterization, and activities for capturing of mouse breast cancer cells 4T1. J. Phys. Chem. C 2016, 120, 23212–23220.
Gao, Z. G.; Tian, L.; Hu, J.; Park, I. S.; Bae, Y. H. Prevention of metastasis in a 4T1 murine breast cancer model by doxorubicin carried by folate conjugated pH sensitive polymeric micelles. J. Control. Release 2011, 152, 84–89.
Liu, S. Q.; Wiradharma, N.; Gao, S. J.; Tong, Y. W.; Yang, Y. Y. Bio- functional micelles self-assembled from a folate-conjugated block copolymer for targeted intracellular delivery of anticancer drugs. Biomaterials 2007, 28, 1423–1433.
Zhu, S. J.; Yang, Q. L.; Antaris, A. L.; Yue, J. Y.; Ma, Z. R.; Wang, H. S.; Huang, W.; Wan, H.; Wang, J.; Diao, S. et al. Molecular imaging of biological systems with a clickable dye in the broad 800- to 1, 700-nm near-infrared window. Proc. Natl. Acad. Sci. USA 2017, 114, 962–967.
Wang, W. Z.; Ma, Z. R.; Zhu, S. J.; Wan, H.; Yue, J. Y.; Ma, H. L.; Ma, R.; Yang, Q. L.; Wang, Z. H.; Li, Q. et al. Molecular cancer imaging in the second near-infrared window using a renal-excreted NIR‐Ⅱ fluorophore- peptide probe. Adv. Mater. 2018, 30, 1800106.
O'Toole, S. A.; Sheppard, B. L.; McGuinness, E. P. J.; Gleeson, N. C.; Yoneda, M.; Bonnar, J. The MTS assay as an indicator of chemosensitivity/ resistance in malignant gynaecological tumours. Cancer Detect. Prev. 2003, 27, 47–54.
Zubris, K. A. V.; Liu, R.; Colby, A.; Schulz, M. D.; Colson, Y. L.; Grinstaff, M. W. In vitro activity of paclitaxel-loaded polymeric expansile nanoparticles in breast cancer cells. Biomacromolecules 2013, 14, 2074–2082.
Yi, X. L.; Lian, X. H.; Dong, J. X.; Wan, Z. Y.; Xia, C. Y.; Song, X.; Fu, Y.; Gong, T.; Zhang, Z. R. Co-delivery of pirarubicin and paclitaxel by human serum albumin nanoparticles to enhance antitumor effect and reduce systemic toxicity in breast cancers. Mol. Pharmaceutics 2015, 12, 4085–4098.
Zhang, X. D.; Wang, H. S.; Antaris, A. L.; Li, L. L.; Diao, S.; Ma, R.; Nguyen, A.; Hong, G. S.; Ma, Z. R.; Wang, J. et al. Traumatic brain injury imaging in the second near‐infrared window with a molecular fluorophore. Adv. Mater. 2016, 28, 6872–6879.
Onda, N.; Kimura, M.; Yoshida, T.; Shibutani, M. Preferential tumor cellular uptake and retention of indocyanine green for in vivo tumor imaging. Int. J. Cancer 2016, 139, 673–682.
Hong, G. S.; Antaris, A. L.; Dai, H. J. Near-infrared fluorophores for biomedical imaging. Nat. Biomed. Eng. 2017, 1, 0010.
Fang, J.; Nakamura, H.; Maeda, H. The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv. Drug Deliv. Rev. 2011, 63, 136–151.
Oh, N.; Park, J. H. Endocytosis and exocytosis of nanoparticles in mammalian cells. Int. J. Nanomedicine 2014, 9, 51–63.
Day, K. E.; Sweeny, L.; Kulbersh, B.; Zinn, K. R.; Rosenthal, E. L. Preclinical comparison of near-infrared-labeled cetuximab and panitumumab for optical imaging of head and neck squamous cell carcinoma. Mol. Imaging Biol. 2013, 15, 722–729.
Knutson, S.; Raja, E.; Bomgarden, R.; Nlend, M.; Chen, A.; Kalyanasundaram, R.; Desai, S. Development and evaluation of a fluorescent antibody-drug conjugate for molecular imaging and targeted therapy of pancreatic cancer. PLoS One 2016, 11, e0157762.
Cheng, Z.; Wu, Y.; Xiong, Z. M.; Gambhir, S. S.; Chen, X. Y. Near- infrared fluorescent RGD peptides for optical imaging of integrin αvβ3 expression in living mice. Bioconjug. Chem. 2005, 16, 1433–1441.
Choi, H. S.; Gibbs, S. L.; Lee, J. H.; Kim, S. H.; Ashitate, Y.; Liu, F. B.; Hyun, H.; Park, G.; Xie, Y.; Bae, S. et al. Targeted zwitterionic near- infrared fluorophores for improved optical imaging. Nat. Biotechnol. 2013, 31, 148–153.
Peng, M. Y.; Qin, S. Y.; Jia, H. Z.; Zheng, D. W.; Rong, L.; Zhang, X. Z. Self-delivery of a peptide-based prodrug for tumor-targeting therapy. Nano Res. 2016, 9, 663–673.
Wang, Z. G.; Fu, B. S.; Zou, S. W.; Duan, B.; Chang, C. Y.; Yang, B.; Zhou, X.; Zhang, L. Facile construction of carbon dots via acid catalytic hydrothermal method and their application for target imaging of cancer cells. Nano Res. 2016, 9, 214–223.
Wang, D. L.; Liu, B.; Ma, Y.; Wu, C. W.; Mou, Q. B.; Deng, H. P.; Wang, R. B.; Yan, D. Y.; Zhang, C.; Zhu, X. Y. A molecular recognition approach to synthesize nucleoside analogue based multifunctional nanoparticles for targeted cancer therapy. J. Am. Chem. Soc. 2017, 139, 14021–14024.
Gelderblom, H.; Verweij, J.; Nooter, K.; Sparreboom, A. Cremophor EL: The drawbacks and advantages of vehicle selection for drug formulation. Eur. J. Cancer 2001, 37, 1590–1598.
京公网安备11010802044758号